"Atrium Health Levine Cancer Institute provides access to top-ranked physician expertise, groundbreaking clinical trials and the latest cancer treatments across the Carolinas."

During the past decade, Levine Cancer Institute-Ballantyne conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Levine Cancer Institute-Ballantyne" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "NRG Oncology" with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Levine Cancer Institute-Ballantyne" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Levine Cancer Institute-Ballantyne" are "Colon Adenocarcinoma" (3 trials), "Prostate Cancer" (2 trials), "Stage IIIA Breast Cancer" (2 trials), "Stage IVA Prostate Cancer AJCC v8" (2 trials) and "Anal Basaloid Carcinoma" (1 trials). Many other conditions were trialed in "Levine Cancer Institute-Ballantyne" in a lesser frequency.

Most popular intervention types in "Levine Cancer Institute-Ballantyne" are "Drug" (15 trials), "Other" (10 trials), "Procedure" (9 trials), "Radiation" (8 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (6 trials), "Biospecimen Collection" (5 trials), "Computed Tomography" (4 trials), "Magnetic Resonance Imaging" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Levine Cancer Institute-Ballantyne" are 12 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Levine Cancer Institute-Ballantyne". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Levine Cancer Institute-Ballantyne, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Levine Cancer Institute-Ballantyne, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".